Related Experiment Video
Updated: Aug 19, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Effects of Loganin on Bone Formation and Resorption In Vitro and In Vivo
Chang-Gun Lee1,2,3, Do-Wan Kim1,4, Jeonghyun Kim1,2
1Department of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
Loganin, a compound from Cornus officinalis, promotes bone health by enhancing osteoblast and suppressing osteoclast activity. This natural compound shows promise for preventing osteoporosis and improving bone density in mice.
Area of Science:
- Biochemistry
- Pharmacology
- Bone Biology
Background:
- Osteoporosis is a prevalent bone remodeling disease in elderly and postmenopausal women.
- Existing osteoporosis treatments have potential side effects.
- Natural compounds offer potential alternative therapeutic strategies.
Purpose of the Study:
- To investigate the effects of loganin, a bioactive compound from Cornus officinalis, on bone metabolism.
- To evaluate loganin's efficacy in vitro and in an in vivo model of osteoporosis.
Main Methods:
- Assessed loganin's impact on osteoblast and osteoclast differentiation in vitro.
- Utilized an ovariectomy (OVX)-induced osteoporosis mouse model for in vivo studies.
- Measured bone mineral density (BMD), microstructure, and serum OPG/RANKL ratio.
Main Results:
- Loganin promoted osteoblast differentiation and inhibited osteoclast differentiation.
- Enhanced alkaline phosphatase (ALP) activity and reduced TRAP activity in co-cultures.
- Prevented OVX-induced bone loss, improved bone parameters, and increased the OPG/RANKL ratio in vivo.
Conclusions:
- Loganin effectively modulates osteoblast and osteoclast activity.
- Oral administration of loganin protects against OVX-induced osteoporosis in mice.
- Loganin presents a potential alternative therapeutic agent for osteoporosis prevention.
More Related Videos
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
08:28A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
Published on: May 21, 2020
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Bone Matrix
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...